Combination therapy for hepatitis C infection

被引:29
作者
Liang, TJ [1 ]
机构
[1] NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1056/NEJM199811193392112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1549 / 1550
页数:2
相关论文
共 17 条
[1]   Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[2]  
[Anonymous], 1998, MMWR MORB MORTAL WKL, V47
[3]   Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial [J].
Bodenheimer, HC ;
Lindsay, KL ;
Davis, GL ;
Lewis, JH ;
Thung, SN ;
Seeff, LB .
HEPATOLOGY, 1997, 26 (02) :473-477
[4]   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].
Davis, GL ;
Esteban-Mur, R ;
Rustgi, V ;
Hoefs, J ;
Gordon, SC ;
Trepo, C ;
Shiffman, ML ;
Zeuzem, S ;
Craxi, A ;
Ling, MH ;
Albrecht, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499
[5]   Lymphoblastoid interferon Alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon Alfa-2b: Results of an international randomized controlled trial [J].
Farrell, GC ;
Bacon, BR ;
Goldin, RD .
HEPATOLOGY, 1998, 27 (04) :1121-1127
[6]   Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C [J].
Gavier, B ;
MartinezGonzalez, MA ;
RiezuBoj, JI ;
Lasarte, JJ ;
Garcia, N ;
Civeira, MP ;
Prieto, J .
GASTROENTEROLOGY, 1997, 113 (05) :1647-1653
[7]  
Heathcote, 1998, HEPATOLOGY, V28, P599
[8]   Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C [J].
Lai, MY ;
Kao, JH ;
Yang, PM ;
Wang, JT ;
Chen, PJ ;
Chan, KW ;
Chu, JS ;
Chen, DS .
GASTROENTEROLOGY, 1996, 111 (05) :1307-1312
[9]   Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].
McHutchison, JG ;
Gordon, SC ;
Schiff, ER ;
Shiffman, ML ;
Lee, WM ;
Rustgi, VK ;
Goodman, ZD ;
Ling, MH ;
Cort, S ;
Albrecht, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492
[10]  
*NIH CONS DEV C PA, 1997, NEW ENGL J MED, V336, P347